Skip to Main Content

Paper Details

Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways.
Kidney Int
17
2020
APOL1, APOL1 gene, APOL1 high-risk variants, APOL1 variants, G1, G2, cardiovascular disease, chronic/end stage kidney, chronic/end stage kidney disease, creatinine, end stage kidney disease, genetic variants, high, high-risk APOL1 variants, kidney dialysis, kidney disease, participants, pre-eclampsia, renal disease
Author NameAffiliation
Aeron M SmallCardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Yale-New Haven Hospital
Wei-Qi WeiVanderbilt University Medical Center
Lisa BastaracheVanderbilt University Medical Center
Lisa BastaracheVanderbilt University Medical Center
QiPing FengVanderbilt University Medical Center
David BirtwellInstitute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania
Christian M ShafferVanderbilt University Medical Center
Joshua C DennyVanderbilt University Medical Center
Daniel J RaderUniversity of Pennsylvania, USA Cardiovascular Institute, Perelman School of Medicine
Charles M SteinVanderbilt University Medical Center, Vanderbilt University
Scott M DamrauerUniversity of Pennsylvania, Corporal Michael Crescenz Veterans Affairs Medical Center
Scott M DamrauerUniversity of Pennsylvania, Corporal Michael Crescenz Veterans Affairs Medical Center
Katalin SusztakUniversity of Pennsylvania, Perelman School of Medicine, USA Cardiovascular Institute
  • 1 - 13

Datasets

Release 1.2